Neuropathix, Inc.
Pharmaceutical company · Doylestown, Pennsylvania, United States
Neuropathix, Inc. is a pharmaceutical company headquartered in Doylestown, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Neuropathix at a glance
Typepharmaceutical company
HeadquartersDoylestown, Pennsylvania, United States
SEC industryPharmaceutical Preparations
SEC CIK1615999
What does Neuropathix do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $1.2 million sold (2021).
Frequently asked questions about Neuropathix
Where is Neuropathix headquartered?
Neuropathix, Inc. is headquartered in Doylestown, Pennsylvania, United States.
What does Neuropathix do?
Neuropathix, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Aprea Therapeutics, Inc.Doylestown, Pennsylvania, United States
- Evrys Bio, LLCDoylestown, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences